Takeda Pharmaceuticals USA Inc.
13 active drug shortages reported by Takeda Pharmaceuticals USA Inc..
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Capsule
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
Lisdexamfetamine Dimesylate Tablet, Chewable
- Category
- Psychiatry
- Reason
- Not specified
- Updated
- 01/09/2026
This information is not medical advice. Consult your pharmacist. Data is sourced from the FDA Drug Shortage Database and may not reflect real-time inventory at your facility. ShortageWatch is independent and not affiliated with the FDA.